The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 23, 2013
Filed:
Jun. 28, 2011
William R. Carling, Bishop's Stortford, GB;
Jose L. Martos, Basildon Essex, GB;
David F. Woodward, Lake Forest, CA (US);
Jenny W. Wang, Irvine, CA (US);
Jussi J. Kangasmetsa, Essex, GB;
William R. Carling, Bishop's Stortford, GB;
Jose L. Martos, Basildon Essex, GB;
David F. Woodward, Lake Forest, CA (US);
Jenny W. Wang, Irvine, CA (US);
Jussi J. Kangasmetsa, Essex, GB;
Allergan, Inc., Irvine, CA (US);
Abstract
The present invention provides a compound, that is a 1-[(2-{[(alkyl or aryl)methyl]oxy}halo or haloalkyl substituted-phenyl)alkyl]-5-hydrocarbyl or substituted hydrocarbyl-1H-pyrazole carboxylic acid or alkylenylcarboxylic acid or a hydrocarbyl or substituted hydrocarbyl sulfonamide of said carboxylic acid or said alkylenylcarboxylic acid, provided however said compound is not a 3-carboxylic acid, a sulfonamide thereof, or a 3-methylenylcarboxylic acid. The compound may be represented by the following formula Wherein R, R, R, R, R, R, X, W, X and Y are as defined in the specification. The compounds may be administered to treat DP1, FP, EP1, TP and/or EP4 receptor mediated diseases or conditions.